T1	Participants 50 75	advanced Hodgkin lymphoma
T2	Participants 445 505	Specimens from the Cancer Cooperative Intergroup Trial E2496
T3	Participants 778 827	Patients with pretreatment EBV(+) plasma (n = 54)
